Brief: XVIVO Perfusion Has Submitted Premarket Approval Application For XPS With STEEN Solution To FDA
May 11 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* XVIVO PERFUSION HAS SUBMITTED PREMARKET APPROVAL
APPLICATION FOR
XPS WITH STEEN SOLUTION TO FDA
Source text for Eikon: ID:nWkr7FNyPM
Further company coverage: XVIVO.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength